The company's AneuGraft stent is designed for lesions located on tortuous coronary vessels.
ITGI Medical Ltd. (TASE:ITGI) has obtained EU CE Mark certification for its AneuGraft stent. Similar to the company’s Over and Under pericardium covered stent, AneuGraft stents are covered with heterologous tissue to address lesions located on tortuous coronary vessels that are hard to navigate for the insertion of stents.
CE Mark certification will enable ITGI to market the AneuGraft stent in Europe for the treatment of treatment of Saphenous Vein Graft (SVG) stenosis, aneurysms, and for emergency situations such as perforations.
ITGI launched its Over and Under pericardium covered stent in the UK, Ireland, and Switzerland in May. The company has distribution agreements for the stent in 16 other countries worldwide, the latest of which is India.
Published by Globes [online], Israel business news - www.globes-online.com - on September 28, 2008
© Copyright of Globes Publisher Itonut (1983) Ltd. 2008